DEBRA WINKLER: Open Payments
NPI 1265064380 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 21 payments from 11 companies in 2025. Trend: 2023 $415 · 2024 $159 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $149 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $55 |
| Ethicon US, LLC | 1 | $41 |
| ABBVIE INC. | 1 | $26 |
| Biogen, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Exeltis, USA Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
| Hologic Sales and Service, LLC | 1 | $14 |
Products named: Veozah, MYFEMBREE, STRATAFIX, BOTOX, ZURZUVAE, GEMTESA, Lynkuet, SLYND.
Industry payments across IN — which companies pay providers there.
